Harvard Bioscience (HBIO) Earnings Date & Reports

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

HBIO is expected to report earnings to rise 15.15% to -37 cents per share on July 30

Harvard Bioscience HBIO Stock Earnings Reports

Q2'26

Est.

$-0.38

Q1'26

Missed

by $0.33

Q4'25

Missed

by $0.10

Q3'25

Missed

by $0.04

Q2'25

Est.

$0.00

The last earnings report on May 12 showed earnings per share of -33 cents, missing the estimate of 0 cents. With 2.43K shares outstanding, the current market capitalization sits at 26.34M.

View a ticker or compare two or three

Compare

HBIO

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for HBIO